In the BioHarmony Drug Report Database

"Preview" Icon

Imipramine

Janimine, Presamine, Tofranil (imipramine) is a small molecule pharmaceutical. Imipramine was first approved as Janimine on 1982-01-01. It is used to treat attention deficit disorder with hyperactivity, depressive disorder, enuresis, pain, and panic disorder amongst others in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter. In addition, it is known to target muscarinic acetylcholine receptor M2, potassium voltage-gated channel subfamily H member 1, G protein-activated inward rectifier potassium channel 2, and G protein-activated inward rectifier potassium channel 4.

 

Trade Name

 

Janimine, Presamine, Tofranil
 

Common Name

 

imipramine
 

ChEMBL ID

 

CHEMBL11
 

Indication

 

attention deficit disorder with hyperactivity, depressive disorder, enuresis, pain, panic disorder, psychotic affective disorders
 

Drug Class

 

Antidepressants (imipramine type)

Image (chem structure or protein)

Imipramine structure rendering